Click for best price
Severe Acute Respiratory Syndrome Treatment Market Size, Share 2024
The global Severe Acute Respiratory Syndrome Treatment market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Antibiotics Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Severe Acute Respiratory Syndrome Treatment include AstraZeneca plc, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Gilead Sciences, Inc., GSK, Merck, Pfizer, Regeneron Pharmaceuticals, Inc. and Swedish Orphan Biovitrum, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
Severe Acute Respiratory Syndrome (SARS) is a viral respiratory illness caused by the SARS coronavirus. There is no specific treatment for SARS; however, treatment typically involves supportive care to relieve symptoms and help the body fight the virus. This could include oxygen therapy, pain & fever management, and breathing support.
This report aims to provide a comprehensive presentation of the global market for Severe Acute Respiratory Syndrome Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Severe Acute Respiratory Syndrome Treatment. This report contains market size and forecasts of Severe Acute Respiratory Syndrome Treatment in global, including the following market information:
Global Severe Acute Respiratory Syndrome Treatment Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global Severe Acute Respiratory Syndrome Treatment Market Sales, 2019-2024, 2025-2030, (K Units)
Global top five Severe Acute Respiratory Syndrome Treatment companies in 2023 (%)
We surveyed the Severe Acute Respiratory Syndrome Treatment manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Severe Acute Respiratory Syndrome Treatment Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Severe Acute Respiratory Syndrome Treatment Market Segment Percentages, by Type, 2023 (%)
Antibiotics
Antivirals
Corticosteroids
Monoclonal Antibodies
Others
Global Severe Acute Respiratory Syndrome Treatment Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Severe Acute Respiratory Syndrome Treatment Market Segment Percentages, by Application, 2023 (%)
Hospital
Retail pharmacies
Others
Global Severe Acute Respiratory Syndrome Treatment Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Severe Acute Respiratory Syndrome Treatment Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Severe Acute Respiratory Syndrome Treatment revenues in global market, 2019-2024 (Estimated), ($ millions)
Key companies Severe Acute Respiratory Syndrome Treatment revenues share in global market, 2023 (%)
Key companies Severe Acute Respiratory Syndrome Treatment sales in global market, 2019-2024 (Estimated), (K Units)
Key companies Severe Acute Respiratory Syndrome Treatment sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZeneca plc
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
Gilead Sciences, Inc.
GSK
Merck
Pfizer
Regeneron Pharmaceuticals, Inc.
Swedish Orphan Biovitrum
CN Bio
AbbVie
Outline of Major Chapters:
Chapter 1: Introduces the definition of Severe Acute Respiratory Syndrome Treatment, market overview.
Chapter 2: Global Severe Acute Respiratory Syndrome Treatment market size in revenue and volume.
Chapter 3: Detailed analysis of Severe Acute Respiratory Syndrome Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Severe Acute Respiratory Syndrome Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Severe Acute Respiratory Syndrome Treatment capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Severe Acute Respiratory Syndrome Treatment Market, Global Outlook and Forecast 2024-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
74 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Severe Acute Respiratory Syndrome Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Severe Acute Respiratory Syndrome Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Severe Acute Respiratory Syndrome Treatment Overall Market Size
2.1 Global Severe Acute Respiratory Syndrome Treatment Market Size: 2023 VS 2030
2.2 Global Severe Acute Respiratory Syndrome Treatment Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Severe Acute Respiratory Syndrome Treatment Sales: 2019-2030
3 Company Landscape
3.1 Top Severe Acute Respiratory Syndrome Treatment Players in Global Market
3.2 Top Global Severe Acute Respiratory Syndrome Treatment Companies Ranked by Revenue
3.3 Global Severe Acute Respiratory Syndrome Treatment Revenue by Companies
3.4 Global Severe Acute Respiratory Syndrome Treatment Sales by Companies
3.5 Global Severe Acute Respiratory Syndrome Treatment Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Severe Acute Respiratory Syndrome Treatment Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Severe Acute Respiratory Syndrome Treatment Product Type
3.8 Tier 1, Tier 2 and Tier 3 Severe Acute Respiratory Syndrome Treatment Players in Global Market
3.8.1 List of Global Tier 1 Severe Acute Respiratory Syndrome Treatment Companies
3.8.2 List of Global Tier 2 and Tier 3 Severe Acute Respiratory Syndrome Treatment Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Severe Acute Respiratory Syndrome Treatment Market Size Markets, 2023 & 2030
4.1.2 Antibiotics
4.1.3 Antivirals
4.1.4 Corticosteroids
4.1.5 Monoclonal Antibodies
4.1.6 Others
4.2 By Type - Global Severe Acute Respiratory Syndrome Treatment Revenue & Forecasts
4.2.1 By Type - Global Severe Acute Respiratory Syndrome Treatment Revenue, 2019-2024
4.2.2 By Type - Global Severe Acute Respiratory Syndrome Treatment Revenue, 2025-2030
4.2.3 By Type - Global Severe Acute Respiratory Syndrome Treatment Revenue Market Share, 2019-2030
4.3 By Type - Global Severe Acute Respiratory Syndrome Treatment Sales & Forecasts
4.3.1 By Type - Global Severe Acute Respiratory Syndrome Treatment Sales, 2019-2024
4.3.2 By Type - Global Severe Acute Respiratory Syndrome Treatment Sales, 2025-2030
4.3.3 By Type - Global Severe Acute Respiratory Syndrome Treatment Sales Market Share, 2019-2030
4.4 By Type - Global Severe Acute Respiratory Syndrome Treatment Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Severe Acute Respiratory Syndrome Treatment Market Size, 2023 & 2030
5.1.2 Hospital
5.1.3 Retail pharmacies
5.1.4 Others
5.2 By Application - Global Severe Acute Respiratory Syndrome Treatment Revenue & Forecasts
5.2.1 By Application - Global Severe Acute Respiratory Syndrome Treatment Revenue, 2019-2024
5.2.2 By Application - Global Severe Acute Respiratory Syndrome Treatment Revenue, 2025-2030
5.2.3 By Application - Global Severe Acute Respiratory Syndrome Treatment Revenue Market Share, 2019-2030
5.3 By Application - Global Severe Acute Respiratory Syndrome Treatment Sales & Forecasts
5.3.1 By Application - Global Severe Acute Respiratory Syndrome Treatment Sales, 2019-2024
5.3.2 By Application - Global Severe Acute Respiratory Syndrome Treatment Sales, 2025-2030
5.3.3 By Application - Global Severe Acute Respiratory Syndrome Treatment Sales Market Share, 2019-2030
5.4 By Application - Global Severe Acute Respiratory Syndrome Treatment Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Severe Acute Respiratory Syndrome Treatment Market Size, 2023 & 2030
6.2 By Region - Global Severe Acute Respiratory Syndrome Treatment Revenue & Forecasts
6.2.1 By Region - Global Severe Acute Respiratory Syndrome Treatment Revenue, 2019-2024
6.2.2 By Region - Global Severe Acute Respiratory Syndrome Treatment Revenue, 2025-2030
6.2.3 By Region - Global Severe Acute Respiratory Syndrome Treatment Revenue Market Share, 2019-2030
6.3 By Region - Global Severe Acute Respiratory Syndrome Treatment Sales & Forecasts
6.3.1 By Region - Global Severe Acute Respiratory Syndrome Treatment Sales, 2019-2024
6.3.2 By Region - Global Severe Acute Respiratory Syndrome Treatment Sales, 2025-2030
6.3.3 By Region - Global Severe Acute Respiratory Syndrome Treatment Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Severe Acute Respiratory Syndrome Treatment Revenue, 2019-2030
6.4.2 By Country - North America Severe Acute Respiratory Syndrome Treatment Sales, 2019-2030
6.4.3 US Severe Acute Respiratory Syndrome Treatment Market Size, 2019-2030
6.4.4 Canada Severe Acute Respiratory Syndrome Treatment Market Size, 2019-2030
6.4.5 Mexico Severe Acute Respiratory Syndrome Treatment Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Severe Acute Respiratory Syndrome Treatment Revenue, 2019-2030
6.5.2 By Country - Europe Severe Acute Respiratory Syndrome Treatment Sales, 2019-2030
6.5.3 Germany Severe Acute Respiratory Syndrome Treatment Market Size, 2019-2030
6.5.4 France Severe Acute Respiratory Syndrome Treatment Market Size, 2019-2030
6.5.5 U.K. Severe Acute Respiratory Syndrome Treatment Market Size, 2019-2030
6.5.6 Italy Severe Acute Respiratory Syndrome Treatment Market Size, 2019-2030
6.5.7 Russia Severe Acute Respiratory Syndrome Treatment Market Size, 2019-2030
6.5.8 Nordic Countries Severe Acute Respiratory Syndrome Treatment Market Size, 2019-2030
6.5.9 Benelux Severe Acute Respiratory Syndrome Treatment Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Severe Acute Respiratory Syndrome Treatment Revenue, 2019-2030
6.6.2 By Region - Asia Severe Acute Respiratory Syndrome Treatment Sales, 2019-2030
6.6.3 China Severe Acute Respiratory Syndrome Treatment Market Size, 2019-2030
6.6.4 Japan Severe Acute Respiratory Syndrome Treatment Market Size, 2019-2030
6.6.5 South Korea Severe Acute Respiratory Syndrome Treatment Market Size, 2019-2030
6.6.6 Southeast Asia Severe Acute Respiratory Syndrome Treatment Market Size, 2019-2030
6.6.7 India Severe Acute Respiratory Syndrome Treatment Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Severe Acute Respiratory Syndrome Treatment Revenue, 2019-2030
6.7.2 By Country - South America Severe Acute Respiratory Syndrome Treatment Sales, 2019-2030
6.7.3 Brazil Severe Acute Respiratory Syndrome Treatment Market Size, 2019-2030
6.7.4 Argentina Severe Acute Respiratory Syndrome Treatment Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Severe Acute Respiratory Syndrome Treatment Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Severe Acute Respiratory Syndrome Treatment Sales, 2019-2030
6.8.3 Turkey Severe Acute Respiratory Syndrome Treatment Market Size, 2019-2030
6.8.4 Israel Severe Acute Respiratory Syndrome Treatment Market Size, 2019-2030
6.8.5 Saudi Arabia Severe Acute Respiratory Syndrome Treatment Market Size, 2019-2030
6.8.6 UAE Severe Acute Respiratory Syndrome Treatment Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 AstraZeneca plc
7.1.1 AstraZeneca plc Company Summary
7.1.2 AstraZeneca plc Business Overview
7.1.3 AstraZeneca plc Severe Acute Respiratory Syndrome Treatment Major Product Offerings
7.1.4 AstraZeneca plc Severe Acute Respiratory Syndrome Treatment Sales and Revenue in Global (2019-2024)
7.1.5 AstraZeneca plc Key News & Latest Developments
7.2 Eli Lilly and Company
7.2.1 Eli Lilly and Company Company Summary
7.2.2 Eli Lilly and Company Business Overview
7.2.3 Eli Lilly and Company Severe Acute Respiratory Syndrome Treatment Major Product Offerings
7.2.4 Eli Lilly and Company Severe Acute Respiratory Syndrome Treatment Sales and Revenue in Global (2019-2024)
7.2.5 Eli Lilly and Company Key News & Latest Developments
7.3 F. Hoffmann-La Roche Ltd.
7.3.1 F. Hoffmann-La Roche Ltd. Company Summary
7.3.2 F. Hoffmann-La Roche Ltd. Business Overview
7.3.3 F. Hoffmann-La Roche Ltd. Severe Acute Respiratory Syndrome Treatment Major Product Offerings
7.3.4 F. Hoffmann-La Roche Ltd. Severe Acute Respiratory Syndrome Treatment Sales and Revenue in Global (2019-2024)
7.3.5 F. Hoffmann-La Roche Ltd. Key News & Latest Developments
7.4 Gilead Sciences, Inc.
7.4.1 Gilead Sciences, Inc. Company Summary
7.4.2 Gilead Sciences, Inc. Business Overview
7.4.3 Gilead Sciences, Inc. Severe Acute Respiratory Syndrome Treatment Major Product Offerings
7.4.4 Gilead Sciences, Inc. Severe Acute Respiratory Syndrome Treatment Sales and Revenue in Global (2019-2024)
7.4.5 Gilead Sciences, Inc. Key News & Latest Developments
7.5 GSK
7.5.1 GSK Company Summary
7.5.2 GSK Business Overview
7.5.3 GSK Severe Acute Respiratory Syndrome Treatment Major Product Offerings
7.5.4 GSK Severe Acute Respiratory Syndrome Treatment Sales and Revenue in Global (2019-2024)
7.5.5 GSK Key News & Latest Developments
7.6 Merck
7.6.1 Merck Company Summary
7.6.2 Merck Business Overview
7.6.3 Merck Severe Acute Respiratory Syndrome Treatment Major Product Offerings
7.6.4 Merck Severe Acute Respiratory Syndrome Treatment Sales and Revenue in Global (2019-2024)
7.6.5 Merck Key News & Latest Developments
7.7 Pfizer
7.7.1 Pfizer Company Summary
7.7.2 Pfizer Business Overview
7.7.3 Pfizer Severe Acute Respiratory Syndrome Treatment Major Product Offerings
7.7.4 Pfizer Severe Acute Respiratory Syndrome Treatment Sales and Revenue in Global (2019-2024)
7.7.5 Pfizer Key News & Latest Developments
7.8 Regeneron Pharmaceuticals, Inc.
7.8.1 Regeneron Pharmaceuticals, Inc. Company Summary
7.8.2 Regeneron Pharmaceuticals, Inc. Business Overview
7.8.3 Regeneron Pharmaceuticals, Inc. Severe Acute Respiratory Syndrome Treatment Major Product Offerings
7.8.4 Regeneron Pharmaceuticals, Inc. Severe Acute Respiratory Syndrome Treatment Sales and Revenue in Global (2019-2024)
7.8.5 Regeneron Pharmaceuticals, Inc. Key News & Latest Developments
7.9 Swedish Orphan Biovitrum
7.9.1 Swedish Orphan Biovitrum Company Summary
7.9.2 Swedish Orphan Biovitrum Business Overview
7.9.3 Swedish Orphan Biovitrum Severe Acute Respiratory Syndrome Treatment Major Product Offerings
7.9.4 Swedish Orphan Biovitrum Severe Acute Respiratory Syndrome Treatment Sales and Revenue in Global (2019-2024)
7.9.5 Swedish Orphan Biovitrum Key News & Latest Developments
7.10 CN Bio
7.10.1 CN Bio Company Summary
7.10.2 CN Bio Business Overview
7.10.3 CN Bio Severe Acute Respiratory Syndrome Treatment Major Product Offerings
7.10.4 CN Bio Severe Acute Respiratory Syndrome Treatment Sales and Revenue in Global (2019-2024)
7.10.5 CN Bio Key News & Latest Developments
7.11 AbbVie
7.11.1 AbbVie Company Summary
7.11.2 AbbVie Severe Acute Respiratory Syndrome Treatment Business Overview
7.11.3 AbbVie Severe Acute Respiratory Syndrome Treatment Major Product Offerings
7.11.4 AbbVie Severe Acute Respiratory Syndrome Treatment Sales and Revenue in Global (2019-2024)
7.11.5 AbbVie Key News & Latest Developments
8 Global Severe Acute Respiratory Syndrome Treatment Production Capacity, Analysis
8.1 Global Severe Acute Respiratory Syndrome Treatment Production Capacity, 2019-2030
8.2 Severe Acute Respiratory Syndrome Treatment Production Capacity of Key Manufacturers in Global Market
8.3 Global Severe Acute Respiratory Syndrome Treatment Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Severe Acute Respiratory Syndrome Treatment Supply Chain Analysis
10.1 Severe Acute Respiratory Syndrome Treatment Industry Value Chain
10.2 Severe Acute Respiratory Syndrome Treatment Upstream Market
10.3 Severe Acute Respiratory Syndrome Treatment Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Severe Acute Respiratory Syndrome Treatment Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Severe Acute Respiratory Syndrome Treatment in Global Market
Table 2. Top Severe Acute Respiratory Syndrome Treatment Players in Global Market, Ranking by Revenue (2023)
Table 3. Global Severe Acute Respiratory Syndrome Treatment Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Severe Acute Respiratory Syndrome Treatment Revenue Share by Companies, 2019-2024
Table 5. Global Severe Acute Respiratory Syndrome Treatment Sales by Companies, (K Units), 2019-2024
Table 6. Global Severe Acute Respiratory Syndrome Treatment Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Severe Acute Respiratory Syndrome Treatment Price (2019-2024) & (US$/Unit)
Table 8. Global Manufacturers Severe Acute Respiratory Syndrome Treatment Product Type
Table 9. List of Global Tier 1 Severe Acute Respiratory Syndrome Treatment Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Severe Acute Respiratory Syndrome Treatment Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Severe Acute Respiratory Syndrome Treatment Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global Severe Acute Respiratory Syndrome Treatment Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Severe Acute Respiratory Syndrome Treatment Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global Severe Acute Respiratory Syndrome Treatment Sales (K Units), 2019-2024
Table 15. By Type - Global Severe Acute Respiratory Syndrome Treatment Sales (K Units), 2025-2030
Table 16. By Application ? Global Severe Acute Respiratory Syndrome Treatment Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global Severe Acute Respiratory Syndrome Treatment Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Severe Acute Respiratory Syndrome Treatment Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global Severe Acute Respiratory Syndrome Treatment Sales (K Units), 2019-2024
Table 20. By Application - Global Severe Acute Respiratory Syndrome Treatment Sales (K Units), 2025-2030
Table 21. By Region ? Global Severe Acute Respiratory Syndrome Treatment Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global Severe Acute Respiratory Syndrome Treatment Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Severe Acute Respiratory Syndrome Treatment Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global Severe Acute Respiratory Syndrome Treatment Sales (K Units), 2019-2024
Table 25. By Region - Global Severe Acute Respiratory Syndrome Treatment Sales (K Units), 2025-2030
Table 26. By Country - North America Severe Acute Respiratory Syndrome Treatment Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Severe Acute Respiratory Syndrome Treatment Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America Severe Acute Respiratory Syndrome Treatment Sales, (K Units), 2019-2024
Table 29. By Country - North America Severe Acute Respiratory Syndrome Treatment Sales, (K Units), 2025-2030
Table 30. By Country - Europe Severe Acute Respiratory Syndrome Treatment Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Severe Acute Respiratory Syndrome Treatment Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe Severe Acute Respiratory Syndrome Treatment Sales, (K Units), 2019-2024
Table 33. By Country - Europe Severe Acute Respiratory Syndrome Treatment Sales, (K Units), 2025-2030
Table 34. By Region - Asia Severe Acute Respiratory Syndrome Treatment Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Severe Acute Respiratory Syndrome Treatment Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia Severe Acute Respiratory Syndrome Treatment Sales, (K Units), 2019-2024
Table 37. By Region - Asia Severe Acute Respiratory Syndrome Treatment Sales, (K Units), 2025-2030
Table 38. By Country - South America Severe Acute Respiratory Syndrome Treatment Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Severe Acute Respiratory Syndrome Treatment Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America Severe Acute Respiratory Syndrome Treatment Sales, (K Units), 2019-2024
Table 41. By Country - South America Severe Acute Respiratory Syndrome Treatment Sales, (K Units), 2025-2030
Table 42. By Country - Middle East & Africa Severe Acute Respiratory Syndrome Treatment Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Severe Acute Respiratory Syndrome Treatment Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa Severe Acute Respiratory Syndrome Treatment Sales, (K Units), 2019-2024
Table 45. By Country - Middle East & Africa Severe Acute Respiratory Syndrome Treatment Sales, (K Units), 2025-2030
Table 46. AstraZeneca plc Company Summary
Table 47. AstraZeneca plc Severe Acute Respiratory Syndrome Treatment Product Offerings
Table 48. AstraZeneca plc Severe Acute Respiratory Syndrome Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 49. AstraZeneca plc Key News & Latest Developments
Table 50. Eli Lilly and Company Company Summary
Table 51. Eli Lilly and Company Severe Acute Respiratory Syndrome Treatment Product Offerings
Table 52. Eli Lilly and Company Severe Acute Respiratory Syndrome Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 53. Eli Lilly and Company Key News & Latest Developments
Table 54. F. Hoffmann-La Roche Ltd. Company Summary
Table 55. F. Hoffmann-La Roche Ltd. Severe Acute Respiratory Syndrome Treatment Product Offerings
Table 56. F. Hoffmann-La Roche Ltd. Severe Acute Respiratory Syndrome Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 57. F. Hoffmann-La Roche Ltd. Key News & Latest Developments
Table 58. Gilead Sciences, Inc. Company Summary
Table 59. Gilead Sciences, Inc. Severe Acute Respiratory Syndrome Treatment Product Offerings
Table 60. Gilead Sciences, Inc. Severe Acute Respiratory Syndrome Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 61. Gilead Sciences, Inc. Key News & Latest Developments
Table 62. GSK Company Summary
Table 63. GSK Severe Acute Respiratory Syndrome Treatment Product Offerings
Table 64. GSK Severe Acute Respiratory Syndrome Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 65. GSK Key News & Latest Developments
Table 66. Merck Company Summary
Table 67. Merck Severe Acute Respiratory Syndrome Treatment Product Offerings
Table 68. Merck Severe Acute Respiratory Syndrome Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 69. Merck Key News & Latest Developments
Table 70. Pfizer Company Summary
Table 71. Pfizer Severe Acute Respiratory Syndrome Treatment Product Offerings
Table 72. Pfizer Severe Acute Respiratory Syndrome Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 73. Pfizer Key News & Latest Developments
Table 74. Regeneron Pharmaceuticals, Inc. Company Summary
Table 75. Regeneron Pharmaceuticals, Inc. Severe Acute Respiratory Syndrome Treatment Product Offerings
Table 76. Regeneron Pharmaceuticals, Inc. Severe Acute Respiratory Syndrome Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 77. Regeneron Pharmaceuticals, Inc. Key News & Latest Developments
Table 78. Swedish Orphan Biovitrum Company Summary
Table 79. Swedish Orphan Biovitrum Severe Acute Respiratory Syndrome Treatment Product Offerings
Table 80. Swedish Orphan Biovitrum Severe Acute Respiratory Syndrome Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 81. Swedish Orphan Biovitrum Key News & Latest Developments
Table 82. CN Bio Company Summary
Table 83. CN Bio Severe Acute Respiratory Syndrome Treatment Product Offerings
Table 84. CN Bio Severe Acute Respiratory Syndrome Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 85. CN Bio Key News & Latest Developments
Table 86. AbbVie Company Summary
Table 87. AbbVie Severe Acute Respiratory Syndrome Treatment Product Offerings
Table 88. AbbVie Severe Acute Respiratory Syndrome Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 89. AbbVie Key News & Latest Developments
Table 90. Severe Acute Respiratory Syndrome Treatment Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2024 (K Units)
Table 91. Global Severe Acute Respiratory Syndrome Treatment Capacity Market Share of Key Manufacturers, 2021-2024
Table 92. Global Severe Acute Respiratory Syndrome Treatment Production by Region, 2019-2024 (K Units)
Table 93. Global Severe Acute Respiratory Syndrome Treatment Production by Region, 2025-2030 (K Units)
Table 94. Severe Acute Respiratory Syndrome Treatment Market Opportunities & Trends in Global Market
Table 95. Severe Acute Respiratory Syndrome Treatment Market Drivers in Global Market
Table 96. Severe Acute Respiratory Syndrome Treatment Market Restraints in Global Market
Table 97. Severe Acute Respiratory Syndrome Treatment Raw Materials
Table 98. Severe Acute Respiratory Syndrome Treatment Raw Materials Suppliers in Global Market
Table 99. Typical Severe Acute Respiratory Syndrome Treatment Downstream
Table 100. Severe Acute Respiratory Syndrome Treatment Downstream Clients in Global Market
Table 101. Severe Acute Respiratory Syndrome Treatment Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Severe Acute Respiratory Syndrome Treatment Segment by Type in 2023
Figure 2. Severe Acute Respiratory Syndrome Treatment Segment by Application in 2023
Figure 3. Global Severe Acute Respiratory Syndrome Treatment Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Severe Acute Respiratory Syndrome Treatment Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Severe Acute Respiratory Syndrome Treatment Revenue, 2019-2030 (US$, Mn)
Figure 7. Severe Acute Respiratory Syndrome Treatment Sales in Global Market: 2019-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Severe Acute Respiratory Syndrome Treatment Revenue in 2023
Figure 9. By Type - Global Severe Acute Respiratory Syndrome Treatment Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global Severe Acute Respiratory Syndrome Treatment Revenue Market Share, 2019-2030
Figure 11. By Type - Global Severe Acute Respiratory Syndrome Treatment Sales Market Share, 2019-2030
Figure 12. By Type - Global Severe Acute Respiratory Syndrome Treatment Price (US$/Unit), 2019-2030
Figure 13. By Application - Global Severe Acute Respiratory Syndrome Treatment Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global Severe Acute Respiratory Syndrome Treatment Revenue Market Share, 2019-2030
Figure 15. By Application - Global Severe Acute Respiratory Syndrome Treatment Sales Market Share, 2019-2030
Figure 16. By Application - Global Severe Acute Respiratory Syndrome Treatment Price (US$/Unit), 2019-2030
Figure 17. By Region - Global Severe Acute Respiratory Syndrome Treatment Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global Severe Acute Respiratory Syndrome Treatment Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global Severe Acute Respiratory Syndrome Treatment Revenue Market Share, 2019-2030
Figure 20. By Region - Global Severe Acute Respiratory Syndrome Treatment Sales Market Share, 2019-2030
Figure 21. By Country - North America Severe Acute Respiratory Syndrome Treatment Revenue Market Share, 2019-2030
Figure 22. By Country - North America Severe Acute Respiratory Syndrome Treatment Sales Market Share, 2019-2030
Figure 23. US Severe Acute Respiratory Syndrome Treatment Revenue, (US$, Mn), 2019-2030
Figure 24. Canada Severe Acute Respiratory Syndrome Treatment Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico Severe Acute Respiratory Syndrome Treatment Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe Severe Acute Respiratory Syndrome Treatment Revenue Market Share, 2019-2030
Figure 27. By Country - Europe Severe Acute Respiratory Syndrome Treatment Sales Market Share, 2019-2030
Figure 28. Germany Severe Acute Respiratory Syndrome Treatment Revenue, (US$, Mn), 2019-2030
Figure 29. France Severe Acute Respiratory Syndrome Treatment Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. Severe Acute Respiratory Syndrome Treatment Revenue, (US$, Mn), 2019-2030
Figure 31. Italy Severe Acute Respiratory Syndrome Treatment Revenue, (US$, Mn), 2019-2030
Figure 32. Russia Severe Acute Respiratory Syndrome Treatment Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries Severe Acute Respiratory Syndrome Treatment Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux Severe Acute Respiratory Syndrome Treatment Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia Severe Acute Respiratory Syndrome Treatment Revenue Market Share, 2019-2030
Figure 36. By Region - Asia Severe Acute Respiratory Syndrome Treatment Sales Market Share, 2019-2030
Figure 37. China Severe Acute Respiratory Syndrome Treatment Revenue, (US$, Mn), 2019-2030
Figure 38. Japan Severe Acute Respiratory Syndrome Treatment Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea Severe Acute Respiratory Syndrome Treatment Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia Severe Acute Respiratory Syndrome Treatment Revenue, (US$, Mn), 2019-2030
Figure 41. India Severe Acute Respiratory Syndrome Treatment Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America Severe Acute Respiratory Syndrome Treatment Revenue Market Share, 2019-2030
Figure 43. By Country - South America Severe Acute Respiratory Syndrome Treatment Sales Market Share, 2019-2030
Figure 44. Brazil Severe Acute Respiratory Syndrome Treatment Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina Severe Acute Respiratory Syndrome Treatment Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa Severe Acute Respiratory Syndrome Treatment Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa Severe Acute Respiratory Syndrome Treatment Sales Market Share, 2019-2030
Figure 48. Turkey Severe Acute Respiratory Syndrome Treatment Revenue, (US$, Mn), 2019-2030
Figure 49. Israel Severe Acute Respiratory Syndrome Treatment Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia Severe Acute Respiratory Syndrome Treatment Revenue, (US$, Mn), 2019-2030
Figure 51. UAE Severe Acute Respiratory Syndrome Treatment Revenue, (US$, Mn), 2019-2030
Figure 52. Global Severe Acute Respiratory Syndrome Treatment Production Capacity (K Units), 2019-2030
Figure 53. The Percentage of Production Severe Acute Respiratory Syndrome Treatment by Region, 2023 VS 2030
Figure 54. Severe Acute Respiratory Syndrome Treatment Industry Value Chain
Figure 55. Marketing Channels
